EMERALD ADVISERS, LLC – Alnylam Pharmaceuticals, Inc. Transaction History
EMERALD ADVISERS, LLC portfolio value:
$520,000
portfolio value
EMERALD ADVISERS, LLC quarter portfolio value change:
+37.24%
quarter
Alnylam Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -0.80% | -21 shares | 138K | $200.16 | 2.6K |
| Q2 2022 | share | Decrease | -10.73% | -315 shares | -97K | $145.85 | 2.62K |
| Q1 2022 | share | Decrease | -1.81% | -54 shares | -28K | $163.29 | 2.93K |
| Q4 2021 | share | Decrease | -1.39% | -42 shares | -65K | $171.03 | 2.99K |
| Q3 2021 | share | Decrease | -25.85% | -1.05K shares | -121K | $188.81 | 3.03K |
| Q2 2021 | share | 0.00% | 0 shares | 116K | $169.52 | 4.08K | |
| Q1 2021 | share | Decrease | -4.22% | -180 shares | 22K | $141.19 | 4.08K |
| Q4 2020 | share | Decrease | -44.12% | -3.37K shares | -557K | $129.97 | 4.26K |
| Q3 2020 | share | Decrease | -1.16% | -90 shares | -33K | $145.6 | 7.63K |
| Q2 2020 | share | Decrease | -15.75% | -1.44K shares | 146K | $148.11 | 7.72K |
| Q1 2020 | share | Decrease | -1.20% | -111 shares | -70K | $108.85 | 9.17K |
| Q4 2019 | share | Decrease | -12.98% | -1.38K shares | 211K | $115.17 | 9.28K |
| Q3 2019 | share | Decrease | -12.28% | -1.49K shares | -25K | $80.42 | 10.67K |
| Q2 2019 | share | Decrease | -8.25% | -1.09K shares | -356K | $72.56 | 12.16K |
| Q1 2019 | share | Increase | +0.55% | 73 shares | 278K | $93.45 | 13.25K |
| Q4 2018 | share | Decrease | -27.63% | -5.03K shares | -633K | $72.91 | 13.18K |
| Q3 2018 | share | Increase | +2.72% | 483 shares | -153K | $87.52 | 18.21K |
| Q2 2018 | share | Increase | +27.89% | 3.86K shares | 95K | $98.49 | 17.73K |
| Q1 2018 | share | Decrease | -6.70% | -996 shares | -236K | $119.1 | 13.86K |
| Q4 2017 | share | Decrease | -5.89% | -930 shares | 32K | $127.05 | 14.86K |
| Q3 2017 | share | Decrease | -8.83% | -1.52K shares | 474K | $117.49 | 15.79K |
| Q2 2017 | share | Decrease | -53.38% | -19.83K shares | -522K | $79.76 | 17.32K |
| Q1 2017 | share | Decrease | -0.08% | -31 shares | 512K | $51.25 | 37.15K |
| Q4 2016 | share | Decrease | -13.42% | -5.76K shares | -1.51M | $37.44 | 37.18K |
| Q3 2016 | share | Increase | +7.26% | 2.90K shares | 689K | $67.78 | 42.94K |
| Q2 2016 | share | Increase | +57.05% | 14.54K shares | 622K | $55.49 | 40.03K |
| Q1 2016 | share | Increase | +11.16% | 2.55K shares | -559K | $62.77 | 25.49K |